several lines of evidence suggest that overactivity of dopaminergic pathways in some areas of the brain are involved in schizophrenia , but the apparent absence of an increase in dopamine turnover suggests that this hyperactivity could be mediated by a dopamine agonist rather than by dopamine itself .
C0282151
dopaminergic
C0013030
dopamine